On October 31, 2022, Helix BioPharma Corp. closed the transaction. The transaction included participation from directors and insiders for CAD 270,000 of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 CAD | -4.55% | +7.69% | 0.00% |
Apr. 08 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
Mar. 28 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 36.68M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it has received CAD 4.62902 million in funding